Skip to main content

Table 3 Nasal symptoms and RQLQ scores of AR and NAR patient groups

From: Prevalence of allergic and nonallergic rhinitis in a rural area of northern China based on sensitization to specific aeroallergens

 

Clinical ARa

Clinical NARb

P value

Nasal symptoms, VAS (mean ± SD)

 Itching

4.46 ± 3.50

3.09 ± 2.99

< 0.0001

 Sneezing

1.53 ± 2.66

0.90 ± 0.94

< 0.0001

 Rhinorrhea

4.29 ± 3.41

3.01 ± 2.95

0.004

 Congestion

3.99 ± 3.29

3.42 ± 3.06

0.021

RQLQ (mean ± SD)

 Sleep

4.57 ± 4.61

3.17 ± 3.76

0.019

 Non nasal/eyes

8.8 ± 9.08

6.11 ± 7.29

< 0.0001

 Practical problems

4.92 ± 4.81

3.04 ± 3.77

0.459

 Nasal

6.89 ± 5.94

4.57 ± 4.76

< 0.0001

 Eyes

4.77 ± 5.76

2.91 ± 3.83

0.041

 Emotion

5.38 ± 5.74

3.73 ± 4.79

< 0.0001

  1. VAS, visual analogue scale; RQLQ, the rhinoconjunctivitis quality of life questionnaire
  2. aSelf-reported AR subjects showing positive SPT defined as clinical AR patients, b self-reported AR subjects with negative SPT
Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us